ArticleAdvances in therapy2026

Response to Letter to the Editor Regarding: 'Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer'.

Mehmet A Bilen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.